Stockreport

Aclaris Therapeutics initiates Phase 1b proof-of-concept trial of ATI-052 [Yahoo! Finance]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF company's potential best-in-class investigational bispecific anti-TSLP/IL-4Ralpha antibody. “We are experiencing strong momentum in the ATI-052 clinical development prog [Read more]